EverHint – EMA 10/30 Crossover, SMA 20/50 Crossover, EMA 10 + Price + MACD – Top 25 Buy and Top 10 Sell Signals for Jun 08, 2026
Market Context
The sharp 13% decline in the VIX to 18.69 signals a meaningful easing of market fear, creating a more favorable environment for trend-following strategies like the EMA and SMA crossovers in play today. Lower volatility reduces the likelihood of false breakouts and whipsaw signals that typically plague momentum-based systems, meaning crossover signals generated in this environment carry a higher degree of reliability. That said, a VIX still hovering near 19 suggests the market hasn't fully transitioned into a complacent, low-volatility regime, so intraday swings remain capable of testing short-term moving average alignments.
The mixed index performance tells a nuanced story about where risk appetite is flowing. The Nasdaq's outperformance at +0.86% against a slightly negative Dow Jones points to clear rotation toward growth and technology, which directly supports the dominance of Technology as the top signal-generating sector today. This divergence between large-cap industrials and growth-oriented indices is a classic signal that traders are selectively deploying capital rather than broadly buying the market, a condition that tends to reward sector-specific momentum strategies over broad index approaches.
For the MACD-enhanced EMA signals in particular, the current environment is constructive. Trending conditions in Technology, combined with reduced volatility noise, allow MACD histogram expansions to develop more cleanly, giving the EMA 10 + Price + MACD strategy a cleaner read on momentum confirmation. The S&P 500's modest +0.30% gain suggests the broader market is consolidating near highs rather than breaking down, which typically supports continuation signals over reversal setups across all three strategies represented in today's 87-signal pool.
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (15 of 19)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ASB | Associated Banc-Corp | Financial Services | $27.78 | $4.6B |
| 2 | BMI | Badger Meter, Inc. | Technology | $130.34 | $3.8B |
| 3 | CI | Cigna Corporation | Healthcare | $289.61 | $76.6B |
| 4 | CPRI | Capri Holdings Limited | Consumer Cyclical | $19.38 | $2.2B |
| 5 | CRBG | Corebridge Financial, ... | Financial Services | $27.13 | $12.4B |
| 6 | EBC | Eastern Bankshares, Inc. | Financial Services | $20.46 | $4.7B |
| 7 | FHN | First Horizon Corporation | Financial Services | $24.27 | $11.5B |
| 8 | FNB | F.N.B. Corporation | Financial Services | $17.71 | $6.3B |
| 9 | KTB | Kontoor Brands, Inc. | Consumer Cyclical | $72.25 | $4.0B |
| 10 | MUR | Murphy Oil Corporation | Energy | $40.01 | $5.7B |
| 11 | RBC | RBC Bearings Incorporated | Industrials | $590.97 | $18.7B |
| 12 | SKY | Champion Homes, Inc. | Consumer Cyclical | $75.20 | $4.1B |
| 13 | SLM | SLM Corporation | Financial Services | $22.39 | $4.2B |
| 14 | SRAD | Sportradar Group AG | Technology | $15.26 | $4.5B |
| 15 | TECH | Bio-Techne Corporation | Healthcare | $52.65 | $8.2B |
🔴 Sell Signals (5 of 40)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | BAP | Credicorp Ltd. | Financial Services | $319.89 | $25.4B |
| 2 | BIDU | Baidu, Inc. | Communication Services | $119.01 | $40.5B |
| 3 | BN | Brookfield Corporation | Financial Services | $44.23 | $98.9B |
| 4 | BZ | Kanzhun Limited | Communication Services | $13.63 | $6.2B |
| 5 | CHH | Choice Hotels Internat... | Consumer Cyclical | $105.42 | $4.8B |
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🟢 Buy Signals (3 of 3)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ANET | Arista Networks, Inc. | Technology | $156.40 | $196.9B |
| 2 | EOG | EOG Resources, Inc. | Energy | $140.15 | $74.6B |
| 3 | GGAL | Grupo Financiero Galic... | Financial Services | $48.04 | $7.7B |
🔴 Sell Signals (5 of 18)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ACIW | ACI Worldwide, Inc. | Technology | $42.56 | $4.3B |
| 2 | AMX | América Móvil, S.A.B. ... | Communication Services | $24.86 | $74.7B |
| 3 | ASND | Ascendis Pharma A/S | Healthcare | $205.81 | $12.7B |
| 4 | CELC | Celcuity Inc. | Healthcare | $87.43 | $4.3B |
| 5 | CRSP | CRISPR Therapeutics AG | Healthcare | $51.60 | $5.0B |
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (7 of 7)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ABNB | Airbnb, Inc. | Consumer Cyclical | $134.31 | $79.7B |
| 2 | AXP | American Express Company | Financial Services | $312.30 | $213.1B |
| 3 | BBWI | Bath & Body Works, Inc. | Consumer Cyclical | $18.30 | $3.7B |
| 4 | CAG | Conagra Brands, Inc. | Consumer Defensive | $13.15 | $6.3B |
| 5 | DUOL | Duolingo, Inc. | Technology | $117.96 | $5.5B |
| 6 | LMAT | LeMaitre Vascular, Inc. | Healthcare | $95.11 | $2.2B |
| 7 | TNGX | Tango Therapeutics, Inc. | Healthcare | $30.93 | $3.6B |
Field Notes
Sector concentration: Technology (17), Financial Services (16), Consumer Cyclical (13)
Data coverage: 0.0% insider, 0.0% congressional, 0.0% earnings, 8.0% news
Vlad's Take
Today's signals: Strong sector concentration in Technology (17 signals) suggests sector-specific rotation.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.